Type 1 and 2 T helper cell-mediated colitis

Current Opinion in Gastroenterology

Volumn 22, Issue 6, 2006, Pages 651-657

  Dohi, Taeko ^a   Fujihashi, Kohtaro ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Colitis; Mucosal inflammation; T helper 1 cell; T helper 2 cell

Indexed keywords

GAMMA INTERFERON ANTIBODY; INTERFERON GAMMA INDUCIBLE PROTEIN 10 ANTIBODY; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 4 ANTIBODY; NEUROPEPTIDE; OXAZOLONE; SUBSTANCE P; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIBODY PRODUCTION; CELL FUNCTION; CELLULAR IMMUNITY; COLITIS; CYTOKINE PRODUCTION; DOWN REGULATION; ENTERITIS; HELPER CELL; HOMEOSTASIS; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTESTINE MUCOSA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; UPREGULATION;

ANIMALS; COLITIS; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; TH1 CELLS; TH2 CELLS;

EID: 33750374637     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000245545.80160.0f     Document Type: Review

References (81)

1. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-2357.
2. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173.
3. Andersson U, Andersson J, Lindfors A, et al. Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol 1990; 20:1591-1596.
4. + T cell subset with an unrestricted cytokine profile. J Immunol 1989; 143:518-525.
5. + T cell clones. J Immunol 1988; 141:849-855.
6. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260:547-549.
7. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-276.
8. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991; 173:869-879.
9. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170:827-845.
10. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236:944-947.
11. - thymocytes with specific lymphokine secretion. Eur J Immunol 1993; 23:307-310.
12. H2 response and in immunoglobulin E production. Science 1995; 270:1845-1847.
13. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179:1285-1295.
14. + T-cell subsets in vivo. Immunol Rev 1991; 123:189-207.
15. + T cells. J Allergy Clin Immunol 1994; 94:1195-1202.
16. Coffman RL, Seymour BW, Lebman DA, et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988; 102:5-28.
17. Esser C, Radbruch A. Immunoglobulin class switching: molecular and cellular analysis. Annu Rev Immunol 1990; 8:717-735.
18. Finkelman FD, Holmes J, Katona IM, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8:303-333.
19. Mestecky J, Blumberg RS, Kiyono H, McGhee JR. The mucosal immune system. In: Paul WE, editor. Fundamental immunology. Philadelphia: Lippincott Williams & Wilkins; 2003. pp. 965-1020.
20. H2 subsets: doubt no more. Immunol Today 1991; 12:256-257.
21. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-257.
22. D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997; 158:962-967.
23. Jaffe JS, James SP, Mullins GE, et al. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and γ-interferon (γ-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol 1994; 14:299-309.
24. Inoue S, Matsumoto T, Iida M, et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity. Am J Gastroenterol 1999; 94:2441-2446.
25. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112:1169-1178.
26. h2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-435.
27. h2 cells.
28. h1 cell-mediated colitis. IL-23 specifically activates IL-17- and -6-producing T cells for the induction of chronic intestinal inflammation as well as other chronic autoimmune inflammatory diseases.
29. Tato CM, O'Shea JJ. Immunology: what does it mean to be just 17? Nature 2006; 441:166-168.
30. H17 and regulatory T cells. Nature 2006; 441:235-238.
31. Langowski JL, Zhang X, Wu L, et al. IL-23 promotes tumour incidence and growth. Nature 2006; 442:461-465.
32. H17 lineage. Nature 2006; 441:231-234.
33. Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 1994; 72:135-141.
34. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997; 18:555-589.
35. Emmrich J, Seyfarth M, Fleig WE, Emmrich F. Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet 1991; 338:570-571.
36. Mizoguchi A, Mizoguchi E, Chiba C, et al. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med 1996; 183:847-856.
37. Mizoguchi A, Mizoguchi E, Tonegawa S, Bhan AK. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR alpha mutant mice with inflammatory bowel disease. Int Immunol 1996; 8:1387-1394.
38. Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993; 75:274-282.
39. + T cells. J Exp Med 1993; 178:237-244.
40. + T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 1997; 112:1876-1886.
41. Iijima H, Takahashi I, Kishi D, et al. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J Exp Med 1999; 190:607-615.
42. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75:253-261.
43. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-274.
44. + T cells. Immunity 1994; 1:553-562.
45. Neurath MF, Fuss I, Kelsall BL, et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996; 183:2605-2616.
46. + T cells. J Exp Med 1996; 183:2669-2674.
47. Hollander GA, Simpson SJ, Mizoguchi E, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995; 3:27-38.
48. + T cells in an experimental model of colitis. Eur J Immunol 1997; 27:17-25.
49. Duchmann R, Schmitt E, Knolle P, et al. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26:934-938.
50. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3:521-533.
51. Rudolph U, Finegold MJ, Rich SS, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 1995; 10:143-150.
52. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113:1296-1306.
53. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96:795-803.
54. Elson CO, Beagley KW, Sharmanov AT, et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996; 157:2174-2185.
55. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182:1281-1290.
56. Greene MI, Ginsburg CH, Benacerraf B. The regulation of hapten-specific granuloma formation. Clin Immunol Immunopathol 1982; 23:275-285.
57. Miller SD, Butler LD. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells I Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. J Immunol 1983; 131:77-85.
58. Autschbach F, Schurmann G, Qiao L, et al. Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch 1995; 426:51-60.
59. Breese E, Braegger CP, Corrigan CJ, et al. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-131.
60. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-1270.
61. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188:1929-1939.
62. h2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 2000; 119:724-733.
63. Dohi T, Fujihashi K, Rennert PD, et al. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189:1169-1180.
64. h2 cell-type colitis. J Immunol 2001; 167:2781-2790.
65. Iqbal N, Oliver JR, Wagner FH, et al. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 2002; 195:71-84.
66. h2 cells monospecific to a microflora-associated antigen in mice. Gastroenterology 2002; 123:1949-1961.
67. + T cells. Am J Pathol 1996; 148:1503-1515.
68. hi T cells. J Exp Med 1999; 190:1479-1492.
69. De Jong YP, Comiskey M, Kalled SL, et al. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 2000; 119:715-723.
70. Asseman C, Mauze S, Leach MW, et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995-1004.
71. + regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295-302.
72. Dohi T, Fujihashi K, Koga T, et al. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice. Gastroenterology 2003; 124:672-682.
73. high T lymphocytes into nude mice. Inflamm Bowel Dis 2006; 12:89-99.
74. Kawashima R, Kawamura YI, Kato R, et al. IL-13 receptor alpha2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice. Gastroenterology 2006; 131:130-141.
75. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000; 51:289-298.
76. Rutgeerts P. Medical therapy of inflammatory bowel disease. Digestion 1998; 59:453-469.
77. Abad C, Martinez C, Juarranz MG, et al. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 2003; 124:961-971.
78. h1-type colitis in IL-10 knockout mice. J Immunol 2003; 171:3762-3767.
79. Hyun JG, Lee G, Brown JB, et al. Antiinterferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis 2005; 11:799-805.
80. -/- mice. J Immunol 2003; 171:1401-1406.
81. Iijima H, Neurath MF, Nagaishi T, et al. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med 2004; 199:471-482.